Your browser doesn't support javascript.
loading
Correction to: Oral octreotide capsules for the treatment of acromegaly: comparison of 2 phase 3 trial results.
Labadzhyan, Artak; Nachtigall, L B; Fleseriu, M; Gordon, M B; Molitch, M; Kennedy, L; Samson, S L; Greenman, Y; Biermasz, N; Bolanowski, M; Haviv, A; Ludlam, W; Patou, G; Strasburger, C J.
Afiliación
  • Labadzhyan A; Cedars-Sinai Medical Center, Los Angeles, CA, 90048, USA. Artak.Labadzhyan@cshs.org.
  • Nachtigall LB; MGH Neuroendocrine and Pituitary Center, Chestnut Hill, MA, USA.
  • Fleseriu M; Pituitary Center, Oregon Health & Sciences University, Portland, OR, USA.
  • Gordon MB; Allegheny Neuroendocrinology Center, Allegheny General Hospital, Pittsburgh, PA, USA.
  • Molitch M; Northwestern University, Chicago, IL, USA.
  • Kennedy L; Cleveland Clinic Foundation, Cleveland, OH, USA.
  • Samson SL; Mayo Clinic, Jacksonville, FL, USA.
  • Greenman Y; Sourasky Medical Center and Tel Aviv University, Tel Aviv, Israel.
  • Biermasz N; Leiden University Medical Center, Leiden, The Netherlands.
  • Bolanowski M; Wroclaw Medical University, Wroclaw, Poland.
  • Haviv A; Chiasma, Inc., Needham, MA, USA.
  • Ludlam W; Cedars-Sinai Medical Center, Los Angeles, CA, 90048, USA.
  • Patou G; Chiasma, Inc., Needham, MA, USA.
  • Strasburger CJ; Charite Universitatsmedizin, Berlin, Germany.
Pituitary ; 24(6): 954, 2021 Dec.
Article en En | MEDLINE | ID: mdl-34347226
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Idioma: En Año: 2021 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Idioma: En Año: 2021 Tipo del documento: Article